BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 26546467)

  • 1. Clinical characteristics of epilepsy of unknown origin in the Rottweiler breed.
    Heske L; Körberg IB; Nødtvedt A; Jäderlund KH
    Acta Vet Scand; 2015 Nov; 57():75. PubMed ID: 26546467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromide therapy in refractory canine idiopathic epilepsy.
    Podell M; Fenner WR
    J Vet Intern Med; 1993; 7(5):318-27. PubMed ID: 8263851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up.
    Rundfeldt C; Tipold A; Löscher W
    BMC Vet Res; 2015 Sep; 11():228. PubMed ID: 26330063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy.
    Fredsø N; Sabers A; Toft N; Møller A; Berendt M
    Vet J; 2016 Feb; 208():44-9. PubMed ID: 26639829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
    Chang Y; Mellor DJ; Anderson TJ
    J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease progression and treatment response of idiopathic epilepsy in Australian Shepherd dogs.
    Weissl J; Hülsmeyer V; Brauer C; Tipold A; Koskinen LL; Kyöstilä K; Lohi H; Sauter-Louis C; Wolf M; Fischer A
    J Vet Intern Med; 2012; 26(1):116-25. PubMed ID: 22182230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low concentrations of cerebrospinal fluid GABA correlate to a reduced response to phenobarbital therapy in primary canine epilepsy.
    Podell M; Hadjiconstantinou M
    J Vet Intern Med; 1999; 13(2):89-94. PubMed ID: 10225597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of bromide in therapy resistant epilepsy of dogs].
    Schwartz-Porsche D; Jürgens U
    Tierarztl Prax; 1991 Aug; 19(4):395-401. PubMed ID: 1948987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of epilepsy in the Belgian shepherd variants Groenendael and Tervueren born in Denmark 1995-2004.
    Berendt M; Gulløv CH; Christensen SL; Gudmundsdottir H; Gredal H; Fredholm M; Alban L
    Acta Vet Scand; 2008 Dec; 50(1):51. PubMed ID: 19102738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of phenobarbital with bromide as a first-choice antiepileptic drug for treatment of epilepsy in dogs.
    Boothe DM; Dewey C; Carpenter DM
    J Am Vet Med Assoc; 2012 May; 240(9):1073-83. PubMed ID: 22515627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between ABCB1 genotype and seizure outcome in Collies with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Bergman RL; Mealey KL
    J Vet Intern Med; 2012; 26(6):1358-64. PubMed ID: 22998209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy.
    Suiter EJ; Packer RM; Volk HA
    Vet Rec; 2016 Jun; 178(26):652. PubMed ID: 27302918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiepileptic drug therapy.
    Podell M
    Clin Tech Small Anim Pract; 1998 Aug; 13(3):185-92. PubMed ID: 9775509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs.
    Volk HA; Matiasek LA; Luján Feliu-Pascual A; Platt SR; Chandler KE
    Vet J; 2008 Jun; 176(3):310-9. PubMed ID: 17468024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine epilepsy: what can we learn from human seizure disorders?
    Chandler K
    Vet J; 2006 Sep; 172(2):207-17. PubMed ID: 16154785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy.
    Dewey CW; Cerda-Gonzalez S; Levine JM; Badgley BL; Ducoté JM; Silver GM; Cooper JJ; Packer RA; Lavely JA
    J Am Vet Med Assoc; 2009 Dec; 235(12):1442-9. PubMed ID: 20001779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment into the usage of levetiracetam in a canine epilepsy clinic.
    Packer RM; Nye G; Porter SE; Volk HA
    BMC Vet Res; 2015 Feb; 11():25. PubMed ID: 25889090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy beyond seizures: a review of the impact of epilepsy and its comorbidities on health-related quality of life in dogs.
    Packer RM; Volk HA
    Vet Rec; 2015 Sep; 177(12):306-15. PubMed ID: 26405128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.